Brought to you by 
Motorola invests in Clinical MicroSensors' biochip technology
12 Oct 1999
Executive Summary
Motorola will collaborate with Clinical Micro Sensors (DNA biochips) to advance CMS's biochip technology and develop electronics for molecular research for various uses including the detection and treatment of disease. Motorola also has made an up-front equity investment in the company and has an option to invest additional funds.
Deal Industry
- Pharmaceuticals
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Nanotechnology, Chips, etc.
-
Drug Discovery Tools
- Genomics-Proteomics
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Motorola invests in Clinical MicroSensors' biochip technology
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice